Core Viewpoint - The Chongqing state-owned enterprise reform sector experienced a decline of 0.76% on December 12, with heavy losses from Chongqing Pharmaceutical Holdings, while the Shanghai Composite Index rose by 0.41% and the Shenzhen Component Index increased by 0.84% [1] Group 1: Market Performance - The closing price of Chongqing Pharmaceutical Holdings was 6.17, down 4.34%, with a trading volume of 2.4369 million shares and a transaction value of 155.6 million [2] - The overall performance of the Chongqing state-owned enterprise reform sector showed mixed results, with individual stocks experiencing varying degrees of gains and losses [1][2] Group 2: Capital Flow - The net outflow of main funds from the Chongqing state-owned enterprise reform sector was 179 million, while retail investors saw a net inflow of 123 million [2] - The capital flow data indicates that while main funds exited, retail investors were actively buying into certain stocks, suggesting differing investor sentiment [2][3] Group 3: Individual Stock Analysis - Chongqing Water Affairs had a net inflow of 11.7256 million from main funds, while it faced a net outflow from retail investors of 11.3717 million [3] - The stock performance of Chongqing Pharmaceutical Holdings was notably poor, with significant net outflows from both main and retail investors [3]
重庆国企改革板块12月12日跌0.76%,重药控股领跌,主力资金净流出1.79亿元